An affordable Fc-receptor blockade method to treat patients with chronic refractory autoimmune thrombocytopenic purpura

Haematologica

Volumn 86, Issue 5, 2001, Pages 552-553

  Ruiz Argüelles, Guillermo J ^a   López Martínez, Briceida ^b   Flores Martínez, José ^b   Ruiz Argüelles, Alejandro ^b   Pérez Romano, Beatriz ^b  

^a CENTRO DE HEMATOLOGÍA Y MEDICINA INTERNA DE PUEBLA   (Mexico)

^b NONE

Author keywords

Anti D; Purpura; Thrombocytopenic; Treatment

Indexed keywords

ACUTE PHASE PROTEIN; ACUTE PHASE PROTEIN RHO; ACUTE-PHASE PROTEIN RHO; ANTIBODY; FC RECEPTOR; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG ANTAGONISM; ECONOMICS; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOLOGY; LETTER; MALE; MIDDLE AGED; PRESCHOOL CHILD; THROMBOCYTE COUNT;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; AGED; ANTIBODIES; CHILD, PRESCHOOL; CHRONIC DISEASE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECEPTORS, FC;

EID: 0035351275     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Jones HW, Tocantis LM. The history of purpura hemorrhagica. Ann Med Hist 1933; 5:349-59.
2. Tarantino MD, Goldsmith G. Treatment of acute immune thrombocytopenic purpura. Semin Hematol 1998; 35 (Suppl 1):28-35.
3. Pizzuto-Chávez J, Gutiérrez-Espíndola G. Plaquetas y púrpuras trombocitopénicas. In: Ruiz-Argüelles GJ, Editor. Fundamentos de Hematología. 2nd ed. México City: Editorial Médica Panamericana: 1998; p. 289-311.
4. Ambriz R, Muñoz R, Pizzuto J, Quintanar E, Morales-Polanco M, Avilés A. Low-dose autologous in vitro opsonized erythrocytes. Radioimmune method and autologous opsonized erythrocytes for refractory autoimmune thrombocytopenic purpura in adults. Arch Intern Med 1987; 147:105-8.
5. Ruiz-Argüelles GJ, Apreza-Molina MG, Pérez-Romano B, Ruiz-Argüelles A. The infusion of anti-RhO-(D) opsonized erythrocytes may be useful in the treatment of patients, splenectomized or not, with chronic, refractory autoimmune thrombocytopenic purpura: a prospective study. Am J Hematol 1993; 43:72-3.
6. Scaradavou A, Bussel JB. Clinical experience with anti-D in the treatment of idiopathic thrombocytopenic purpura. Semin Hematol 1998; 35 (Suppl 1):52-7.